Advanced search
1 file | 30.75 MB Add to list

Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma

(2023)
Author
Promoter
(UGent) , (UGent) and (UGent)
Organization

Downloads

  • (...).pdf
    • full text (Published version)
    • |
    • UGent only
    • |
    • PDF
    • |
    • 30.75 MB

Citation

Please use this url to cite or link to this publication:

MLA
de Carvalho Nunes, Carolina. Preclinical Evaluation of Targeted Therapeutic Strategies for High-Risk Neuroblastoma. Ghent University. Faculty of Medicine and Health Sciences, 2023.
APA
de Carvalho Nunes, C. (2023). Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma. Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium.
Chicago author-date
Carvalho Nunes, Carolina de. 2023. “Preclinical Evaluation of Targeted Therapeutic Strategies for High-Risk Neuroblastoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Chicago author-date (all authors)
de Carvalho Nunes, Carolina. 2023. “Preclinical Evaluation of Targeted Therapeutic Strategies for High-Risk Neuroblastoma.” Ghent, Belgium: Ghent University. Faculty of Medicine and Health Sciences.
Vancouver
1.
de Carvalho Nunes C. Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma. [Ghent, Belgium]: Ghent University. Faculty of Medicine and Health Sciences; 2023.
IEEE
[1]
C. de Carvalho Nunes, “Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma,” Ghent University. Faculty of Medicine and Health Sciences, Ghent, Belgium, 2023.
@phdthesis{01GX7YWD4DCT65Q80Z23761P66,
  author       = {{de Carvalho Nunes, Carolina}},
  language     = {{eng}},
  pages        = {{196}},
  publisher    = {{Ghent University. Faculty of Medicine and Health Sciences}},
  school       = {{Ghent University}},
  title        = {{Preclinical evaluation of targeted therapeutic strategies for high-risk neuroblastoma}},
  year         = {{2023}},
}